Calumet County Health Dept Hhc Agency | |
206 Court St Courthouse, Chilton, Wisconsin 53014 | |
(920) 849-1432 | |
Name | Calumet County Health Dept Hhc Agency |
---|---|
Location | 206 Court St Courthouse, Chilton, Wisconsin |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Home Health Aide |
Medicare ID | 527085 |
Ownership Type | Government - State/county |
Service Area Zip Codes | 53014, 53016, 53042, 53057, 53061, 53079, 53088, 54110, 54129, 54160, 54169, 54207, 54232, 54915, 54952 |
NPI Number | 1396736831 |
Organization Name | CALUMET COUNTY |
Doing Business As | CALUMET COUNTY HOME HEALTHCARE |
Address | 206 Court St, Chilton, WI 53014 |
Phone Number | 920-849-1432 |
News Archive
SOFIE BIOSCIENCES, a leader in the field of Positron Emission Tomography (PET) imaging, including probes, scanners, and chemistry systems, announced today that the National Cancer Institute has awarded the company a Phase II Small Business Innovation Research (SBIR) contract for approximately $1.5M over two years.
Aduro BioTech, Inc., a clinical stage biotechnology company, today announced the presentation of safety and efficacy data from a Phase 1b clinical trial of its novel immunotherapy CRS-207 in combination with standard chemotherapy in patients with unresectable malignant pleural mesothelioma.
Avita Medical Ltd., a medical device company specializing in the treatment of wounds and skin defects, today said a branch of the U.S. Military says the U.S. Department of Defense ‘wants to use' the company's ReCell technology, which it described as offering a possible ‘paradigm shift' in skin injury treatment.
A scoring system known as the supraglottic index is valuable in assessing patients with asthma complicated by laryngopharyngeal reflux, researchers report.
› Verified 1 days ago
Quality Rating: |
News Archive
SOFIE BIOSCIENCES, a leader in the field of Positron Emission Tomography (PET) imaging, including probes, scanners, and chemistry systems, announced today that the National Cancer Institute has awarded the company a Phase II Small Business Innovation Research (SBIR) contract for approximately $1.5M over two years.
Aduro BioTech, Inc., a clinical stage biotechnology company, today announced the presentation of safety and efficacy data from a Phase 1b clinical trial of its novel immunotherapy CRS-207 in combination with standard chemotherapy in patients with unresectable malignant pleural mesothelioma.
Avita Medical Ltd., a medical device company specializing in the treatment of wounds and skin defects, today said a branch of the U.S. Military says the U.S. Department of Defense ‘wants to use' the company's ReCell technology, which it described as offering a possible ‘paradigm shift' in skin injury treatment.
A scoring system known as the supraglottic index is valuable in assessing patients with asthma complicated by laryngopharyngeal reflux, researchers report.
› Verified 1 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 100 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 97 | 98.6 |
How often the home health team checked patients’ risk of falling | 100 | 99.6 |
How often the home health team checked patients for depression | 100 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 75.3 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 87.1 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 97.2 | 96.4 |
News Archive
SOFIE BIOSCIENCES, a leader in the field of Positron Emission Tomography (PET) imaging, including probes, scanners, and chemistry systems, announced today that the National Cancer Institute has awarded the company a Phase II Small Business Innovation Research (SBIR) contract for approximately $1.5M over two years.
Aduro BioTech, Inc., a clinical stage biotechnology company, today announced the presentation of safety and efficacy data from a Phase 1b clinical trial of its novel immunotherapy CRS-207 in combination with standard chemotherapy in patients with unresectable malignant pleural mesothelioma.
Avita Medical Ltd., a medical device company specializing in the treatment of wounds and skin defects, today said a branch of the U.S. Military says the U.S. Department of Defense ‘wants to use' the company's ReCell technology, which it described as offering a possible ‘paradigm shift' in skin injury treatment.
A scoring system known as the supraglottic index is valuable in assessing patients with asthma complicated by laryngopharyngeal reflux, researchers report.
› Verified 1 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 72.1 | 79.6 |
How often patients got better at getting in and out of bed | 76.2 | 81.1 |
How often patients got better at bathing | 74 | 82.3 |
How often patients’ breathing improved | 73.1 | 82.8 |
How often patients’ wounds improved or healed after an operation | - | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 73.3 | 75 |
How often home health patients had to be admitted to the hospital | 7.8 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 17.7 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 99.2 | 94 |
News Archive
SOFIE BIOSCIENCES, a leader in the field of Positron Emission Tomography (PET) imaging, including probes, scanners, and chemistry systems, announced today that the National Cancer Institute has awarded the company a Phase II Small Business Innovation Research (SBIR) contract for approximately $1.5M over two years.
Aduro BioTech, Inc., a clinical stage biotechnology company, today announced the presentation of safety and efficacy data from a Phase 1b clinical trial of its novel immunotherapy CRS-207 in combination with standard chemotherapy in patients with unresectable malignant pleural mesothelioma.
Avita Medical Ltd., a medical device company specializing in the treatment of wounds and skin defects, today said a branch of the U.S. Military says the U.S. Department of Defense ‘wants to use' the company's ReCell technology, which it described as offering a possible ‘paradigm shift' in skin injury treatment.
A scoring system known as the supraglottic index is valuable in assessing patients with asthma complicated by laryngopharyngeal reflux, researchers report.
› Verified 1 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | |
Health team communicated well with them | |
Health team discussed medicines, pain, and home safety | |
How patients rated overall care from agency |
News Archive
SOFIE BIOSCIENCES, a leader in the field of Positron Emission Tomography (PET) imaging, including probes, scanners, and chemistry systems, announced today that the National Cancer Institute has awarded the company a Phase II Small Business Innovation Research (SBIR) contract for approximately $1.5M over two years.
Aduro BioTech, Inc., a clinical stage biotechnology company, today announced the presentation of safety and efficacy data from a Phase 1b clinical trial of its novel immunotherapy CRS-207 in combination with standard chemotherapy in patients with unresectable malignant pleural mesothelioma.
Avita Medical Ltd., a medical device company specializing in the treatment of wounds and skin defects, today said a branch of the U.S. Military says the U.S. Department of Defense ‘wants to use' the company's ReCell technology, which it described as offering a possible ‘paradigm shift' in skin injury treatment.
A scoring system known as the supraglottic index is valuable in assessing patients with asthma complicated by laryngopharyngeal reflux, researchers report.
› Verified 1 days ago
The patient survey data of Calumet County Health Dept Hhc Agency is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 91 | 88 |
Percent of patients who reported that their home health team communicated well with them | 85 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 89 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 91 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 86 | 78 |
News Archive
SOFIE BIOSCIENCES, a leader in the field of Positron Emission Tomography (PET) imaging, including probes, scanners, and chemistry systems, announced today that the National Cancer Institute has awarded the company a Phase II Small Business Innovation Research (SBIR) contract for approximately $1.5M over two years.
Aduro BioTech, Inc., a clinical stage biotechnology company, today announced the presentation of safety and efficacy data from a Phase 1b clinical trial of its novel immunotherapy CRS-207 in combination with standard chemotherapy in patients with unresectable malignant pleural mesothelioma.
Avita Medical Ltd., a medical device company specializing in the treatment of wounds and skin defects, today said a branch of the U.S. Military says the U.S. Department of Defense ‘wants to use' the company's ReCell technology, which it described as offering a possible ‘paradigm shift' in skin injury treatment.
A scoring system known as the supraglottic index is valuable in assessing patients with asthma complicated by laryngopharyngeal reflux, researchers report.
› Verified 1 days ago
Calumet County Health Dept Hhc Agency Location: 206 Court St Courthouse, Chilton, Wisconsin 53014 Ratings: Phone: (920) 849-1432 |